Susquehanna International Group, LLP Fusion Pharmaceuticals Inc. Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
BUY
$7.9 - $21.32 $1.02 Million - $2.75 Million
129,082 Added 699.06%
147,547 $3.15 Million
Q4 2023

Feb 14, 2024
BUY
$2.48 - $9.65 $45,793 - $178,187
18,465 New
18,465 $177,000
Q2 2021

Aug 11, 2021
SELL
$7.97 - $10.66 $85,637 - $114,541
-10,745 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$9.75 - $13.09 $104,763 - $140,652
10,745 New
10,745 $115,000

Others Institutions Holding FUSN

# of Institutions
5
Shares Held
93K
Call Options Held
1.4K
Put Options Held
0
View Full List

About Fusion Pharmaceuticals Inc.

FUSN Quotes by TradingView
  • Ticker FUSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,390,500
  • Description
  • Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...
More about FUSN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email